A detailed history of Deutsche Bank Ag\ transactions in Cassava Sciences Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 25,631 shares of SAVA stock, worth $61,770. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,631
Previous 19,317 32.69%
Holding current value
$61,770
Previous $238,000 216.81%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$9.57 - $35.08 $60,424 - $221,495
6,314 Added 32.69%
25,631 $754,000
Q2 2024

Aug 14, 2024

SELL
$12.35 - $26.11 $26,824 - $56,710
-2,172 Reduced 10.11%
19,317 $238,000
Q1 2024

May 15, 2024

BUY
$18.44 - $26.41 $6,306 - $9,032
342 Added 1.62%
21,489 $436,000
Q4 2023

Feb 14, 2024

SELL
$12.64 - $30.11 $5,195 - $12,375
-411 Reduced 1.91%
21,147 $476,000
Q3 2023

Nov 09, 2023

BUY
$16.64 - $25.32 $21,149 - $32,181
1,271 Added 6.27%
21,558 $358,000
Q2 2023

Aug 14, 2023

SELL
$21.59 - $27.88 $197,958 - $255,631
-9,169 Reduced 31.13%
20,287 $497,000
Q1 2023

May 15, 2023

BUY
$23.46 - $36.44 $187,820 - $291,738
8,006 Added 37.32%
29,456 $710,000
Q4 2022

Feb 13, 2023

BUY
$27.82 - $44.16 $55,918 - $88,761
2,010 Added 10.34%
21,450 $633,000
Q3 2022

Nov 14, 2022

SELL
$16.33 - $51.06 $70,316 - $219,864
-4,306 Reduced 18.13%
19,440 $813,000
Q2 2022

Aug 11, 2022

SELL
$17.22 - $38.47 $5,992 - $13,387
-348 Reduced 1.44%
23,746 $667,000
Q1 2022

May 13, 2022

SELL
$32.6 - $53.05 $69,242 - $112,678
-2,124 Reduced 8.1%
24,094 $895,000
Q4 2021

Feb 11, 2022

SELL
$36.77 - $90.91 $2.65 Million - $6.56 Million
-72,203 Reduced 73.36%
26,218 $1.15 Million
Q3 2021

Nov 04, 2021

BUY
$41.79 - $135.3 $3.03 Million - $9.8 Million
72,437 Added 278.78%
98,421 $6.11 Million
Q2 2021

Aug 11, 2021

BUY
$32.15 - $89.72 $146,057 - $407,597
4,543 Added 21.19%
25,984 $2.22 Million
Q1 2021

May 13, 2021

SELL
$7.09 - $87.95 $10,592 - $131,397
-1,494 Reduced 6.51%
21,441 $963,000
Q4 2020

Feb 16, 2021

BUY
$6.79 - $12.25 $75,660 - $136,501
11,143 Added 94.5%
22,935 $156,000
Q3 2020

Nov 12, 2020

BUY
$2.86 - $11.51 $3,214 - $12,937
1,124 Added 10.54%
11,792 $136,000
Q2 2020

Aug 13, 2020

BUY
$2.04 - $9.64 $21,762 - $102,839
10,668 New
10,668 $33,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $96.6M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.